Bronchoscopic biopsy of peripheral pulmonary lesions in 2020: a review of existing technologies.

ABSTRACT: There are over 200,000 new cases of lung cancer diagnosed annually in the United States resulting in nearly 150,000 deaths, making lung cancer the most lethal of all forms of cancer. Only 1 in 6 lung cancers are diagnosed at an early stage an over half are diagnosed with distant metastasis. Despite advances in screening and treatment, the 5-year survival rate for all lung cancers remains low, around 20%. The advent of effective lung cancer screening with low-dose computed tomography has started to shift diagnosis to earlier stages. Screening, along with the ever-increasing use of chest CT, have led to an exponential increase in the detection of indeterminate lung nodules. For many nodules, effective diagnosis relies on invasive tissue sample collection. Advances in bronchoscopic technology

SUBMITTER: Katsis JM 

PROVIDER: S-EPMC7330747 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature